Foster City, California Thursday, February 20, 2025, 12:00 Hrs [IST] ...

A recently approved drug has shown promise in reducing heart attacks and strokes in patients with type 2 diabetes and kidney disease. This medication, a sodium-glucose cotransporter (SGLT) inhibitor, ...

Download the full document here: 25-909, Integrating the Maneuver Enhancement Brigade [PDF - 15 MB] ...

Acting in the right place at the right time is the key to effective medical treatment with minimal side effects. However, ...

The FDA has accepted a priority review of a new biannual HIV prevention injection, with a decision expected by June 19, 2025.

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help lower their stroke and heart attack risk, a new study has found.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

SaveHealth provides an overview of DHT shampoos, including pros, cons, and what kinds of issues they best solve.

Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...